An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

NCT01406119 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ABT-806

Sponsor

AbbVie (prior sponsor, Abbott)